{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:55:30Z","timestamp":1790931330589,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2012_A103, 2015_A228"],"award-info":[{"award-number":["2012_A103, 2015_A228"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RE752\/30-1, 314061271-TRR 205"],"award-info":[{"award-number":["RE752\/30-1, 314061271-TRR 205"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00259-026-08002-1","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T02:29:16Z","timestamp":1782440956000},"page":"7350-7358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genotype-dependent [18F]FDOPA uptake: quantitative evidence from a genetically stratified PPGL cohort"],"prefix":"10.1007","volume":"53","author":[{"given":"Paul","family":"Dahlmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Geuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Auer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Disko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeel","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Schmid-Tannwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"N\u00f6lting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Reisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lottspeich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kroiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6157-0363","authenticated-orcid":false,"given":"Friederike","family":"V\u00f6lter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"3","key":"8002_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12022-017-9484-5","volume":"28","author":"AK Lam","year":"2017","unstructured":"Lam AK. Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours. Endocr Pathol. 2017;28(3):213\u201327.","journal-title":"Endocr Pathol"},{"issue":"2","key":"8002_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1210\/jc.2010-1588","volume":"96","author":"G Eisenhofer","year":"2011","unstructured":"Eisenhofer G, et al. Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location. J Clin Endocrinol Metab. 2011;96(2):375\u201384.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"8002_CR3","first-page":"69","volume":"38","author":"G Eisenhofer","year":"2017","unstructured":"Eisenhofer G, et al. Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing. Clin Biochem Rev. 2017;38(2):69\u2013100.","journal-title":"Clin Biochem Rev"},{"issue":"2","key":"8002_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1210\/endrev\/bnab019","volume":"43","author":"S N\u00f6lting","year":"2022","unstructured":"N\u00f6lting S, et al. Personalized Management of Pheochromocytoma and Paraganglioma. Endocr Rev. 2022;43(2):199\u2013239.","journal-title":"Endocr Rev"},{"issue":"2","key":"8002_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017;31(2):181\u201393.","journal-title":"Cancer Cell"},{"issue":"4","key":"8002_CR6","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1210\/jc.2018-02411","volume":"104","author":"A Buffet","year":"2019","unstructured":"Buffet A, et al. Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and\/or Pheochromocytoma. J Clin Endocrinol Metab. 2019;104(4):1109\u201318.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"8002_CR7","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JWM Lenders","year":"2014","unstructured":"Lenders JWM, et al. Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metabolism. 2014;99(6):1915\u201342.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"10","key":"8002_CR8","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","volume":"46","author":"D Ta\u00efeb","year":"2019","unstructured":"Ta\u00efeb D, et al. European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2019;46(10):2112\u201337.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"8002_CR9","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1210\/endrev\/bnae001","volume":"45","author":"H Timmers","year":"2024","unstructured":"Timmers H, et al. Imaging of Pheochromocytomas and Paragangliomas. Endocr Rev. 2024;45(3):414\u201334.","journal-title":"Endocr Rev"},{"issue":"12","key":"8002_CR10","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41574-024-01024-5","volume":"20","author":"RT Casey","year":"2024","unstructured":"Casey RT, et al. International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents. Nat Rev Endocrinol. 2024;20(12):729\u201348.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"8002_CR11","doi-asserted-by":"publisher","first-page":"e0156044","DOI":"10.1371\/journal.pone.0156044","volume":"11","author":"S Barollo","year":"2016","unstructured":"Barollo S, et al. Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors. PLoS ONE. 2016;11(5):e0156044.","journal-title":"PLoS ONE"},{"issue":"4","key":"8002_CR12","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s40618-024-02515-y","volume":"48","author":"V Berti","year":"2025","unstructured":"Berti V, et al. Deciphering (18)F-DOPA uptake in SDH-related head and neck paragangliomas: a radiomics approach. J Endocrinol Invest. 2025;48(4):941\u201350.","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"8002_CR13","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1007\/s00259-019-04332-5","volume":"46","author":"W Noordzij","year":"2019","unstructured":"Noordzij W, et al. Adrenal tracer uptake by (18)F-FDOPA PET\/CT in patients with pheochromocytoma and controls. Eur J Nucl Med Mol Imaging. 2019;46(7):1560\u20136.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"8002_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s41824-025-00275-3","volume":"9","author":"P Dahlmann","year":"2025","unstructured":"Dahlmann P, et al. Quantitative [(18)F]FDOPA PET\/CT for the characterization of biochemical phenotypes in paraganglioma and pheochromocytoma. EJNMMI Rep. 2025;9(1):40.","journal-title":"EJNMMI Rep"},{"issue":"5","key":"8002_CR15","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1210\/endrev\/bnad011","volume":"44","author":"G Eisenhofer","year":"2023","unstructured":"Eisenhofer G, Pamporaki C, Lenders JWM. Biochemical Assessment of Pheochromocytoma and Paraganglioma. Endocr Rev. 2023;44(5):862\u2013909.","journal-title":"Endocr Rev"},{"issue":"11","key":"8002_CR16","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/clinem\/dgae241","volume":"109","author":"K Wang","year":"2024","unstructured":"Wang K, et al. Opposing Effects of Cannabidiol in Patient-derived Neuroendocrine Tumor, Pheochromocytoma\/Paraganglioma Primary Cultures. J Clin Endocrinol Metab. 2024;109(11):2892\u2013904.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"8002_CR17","first-page":"e220091","volume":"3","author":"JV Lima Jr","year":"2023","unstructured":"Lima JV Jr., et al. Germline genetic variants in pheochromocytoma\/paraganglioma: single-center experience. Endocr Oncol. 2023;3(1):e220091.","journal-title":"Endocr Oncol"},{"issue":"12","key":"8002_CR18","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1210\/jc.2009-1248","volume":"94","author":"HJLM Timmers","year":"2009","unstructured":"Timmers HJLM, et al. Comparison of 18F-Fluoro-L-DOPA, 18F-Fluoro-Deoxyglucose, and 18F-Fluorodopamine PET and 123I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma. J Clin Endocrinol Metabolism. 2009;94(12):4757\u201367.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"5","key":"8002_CR19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s00259-016-3586-z","volume":"44","author":"CC Feral","year":"2017","unstructured":"Feral CC, et al. (18)F-fluorodihydroxyphenylalanine PET\/CT in pheochromocytoma and paraganglioma: relation to genotype and amino acid transport system L. Eur J Nucl Med Mol Imaging. 2017;44(5):812\u201321.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"8002_CR20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.2214\/AJR.21.26071","volume":"218","author":"A Jha","year":"2021","unstructured":"Jha A, et al. Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET\/CT Using 68Ga-DOTATATE, FDG, 18F-FDOPA, and 18F-FDA). Am J Roentgenol. 2021;218(2):342\u201350.","journal-title":"Am J Roentgenol"},{"issue":"3","key":"8002_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000491578","volume":"107","author":"S Moog","year":"2018","unstructured":"Moog S, et al. 18F-FDOPA PET\/CT Uptake Parameters Correlate with Catecholamine Secretion in Human Pheochromocytomas. Neuroendocrinology. 2018;107(3):228\u201336.","journal-title":"Neuroendocrinology"},{"issue":"5","key":"8002_CR22","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1210\/jcem.86.5.7496","volume":"86","author":"G Eisenhofer","year":"2001","unstructured":"Eisenhofer G, et al. Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab. 2001;86(5):1999\u20132008.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"8002_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1677\/ERC-10-0211","volume":"18","author":"G Eisenhofer","year":"2011","unstructured":"Eisenhofer G, et al. Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocr Relat Cancer. 2011;18(1):97\u2013111.","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"8002_CR24","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1210\/jc.2017-02324","volume":"103","author":"D Ta\u00efeb","year":"2018","unstructured":"Ta\u00efeb D, et al. 18F-FDOPA PET\/CT Imaging of MAX-Related Pheochromocytoma. J Clin Endocrinol Metab. 2018;103(4):1574\u201382.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"8002_CR25","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","volume":"18","author":"N Burnichon","year":"2012","unstructured":"Burnichon N, et al. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin Cancer Res. 2012;18(10):2828\u201337.","journal-title":"Clin Cancer Res"},{"key":"8002_CR26","doi-asserted-by":"publisher","first-page":"609263","DOI":"10.3389\/fendo.2021.609263","volume":"12","author":"DB Duarte","year":"2021","unstructured":"Duarte DB, et al. Case Report: Pheochromocytoma and Synchronous Neuroblastoma in a Family With Hereditary Pheochromocytoma Associated With a MAX Deleterious Variant. Front Endocrinol (Lausanne). 2021;12:609263.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"8002_CR27","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.2967\/jnumed.111.101303","volume":"53","author":"HC Rischke","year":"2012","unstructured":"Rischke HC, et al. Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy PET. J Nucl Med. 2012;53(9):1352\u20138. -6-18F-fluoro-L-phenylalanin.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08002-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-08002-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08002-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:32:12Z","timestamp":1790929932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-08002-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["8002"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-08002-1","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed according to the Declaration of Helsinki (1991) and was approved by the local ethics committee (Medical Faculty, LMU Munich, Munich, Germany, application number 23\u20130689).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RAW received speaker honoraria from Novartis\/AAA and PentixaPharm and reports advisory board work for Novartis\/AAA and Bayer. MR reports speaker\u2019s honoraria and consulting by Novartis, Pfizer, Recordati Rare Disease, Ipsen, HRA Pharma, Crinetics, Lundbeck.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}